[redactions made under s47F of the FOI Act]
From:
Sent:
Wednesday, 16 February 2022 12:22 PM
To:
Clinical Guidelines; Goodrick, Stephanie
Cc:
Hoffman, Sharon;
Mark Bellgrove
Subject:
Re: NHMRC Meetings 2022 [SEC=OFFICIAL]
Thank you Steph!
The public consultation period is expected to run for 30 days from: 7th March - 5th April 2022.
Best wishes,
Monash University Teaching Associate, Faculty of Medicine, Nursing & Health Sciences
E:
I acknowledge the Traditional Owners and Custodians of the lands on which I live and
work and pay my respect to Elders both past and present.
On 16/02/2022 11:58 am, Clinical Guidelines wrote:
Hi
Yes the June progress report should be fine and you can send the names separately.
Can I get back to you on the 14 June submission date? I need to check with our Council secretariat,
but we could potentially commission expert and methodological review on the public consultation
draft which would then mean the 14 June submission date would work.
Just confirming again you are likely to release the public consultation draft at the beginning of
March (in 2 weeks!)?
Thanks
Steph
From: Sent: Wednesday, 16 February 2022 11:22 AM
To: Goodrick, Stephanie <xxxxxxxxx.xxxxxxxx@xxxxx.xxx.xx>
Cc: Hoffman, Sharon <xxxxxx.xxxxxxx@xxxxx.xxx.xx>;
Mark Bellgrove
<xxxx.xxxxxxxxx@xxxxxx.xxx>; Clinical Guidelines <xxxxxxxxxxxxxxxxxx@xxxxx.xxx.xx>
Subject: Re: NHMRC Meetings 2022 [SEC=OFFICIAL]
Hi Stephanie and Sharon,
Thank you for your response. Just to clarify, we submitted a progress report in June in
anticipation of public consultation last year but due to various uncontrollable delays public
consultation didn't eventuate. Apart from the reviewer names, we don't have anything to add
so will the June progress report be sufficient and we will send you the reviewer names
separately as soon as we can?
1
Might there be any possibility that we could submit on 14 June?
Thank you and best wishes,
Monash University Teaching Associate, Faculty of Medicine, Nursing &
Health Sciences
E:
I acknowledge the Traditional Owners and Custodians of the lands on which
I live and work and pay my respect to Elders both past and present.
On 15/02/2022 4:56 pm, Goodrick, Stephanie wrote:
Thanks
.
Yes xxxxxxxxxxxxxxxxxx@xxxxx.xxx.xx is the correct address to send
correspondence to – addressed to Sharon Hoffman (copied).
For expert reviewers – could you please send us around six names and contact
details? We also contact a few additional experts identified through our contacts.
Ideally these names are sent to us along with the progress report ‐ so before public
consultation opens.
To meet the July meeting could you please submit the guidelines to us by 31 May
2022. If there are any problems with this please let us know.
Thanks
Steph
Stephanie Goodrick | Assistant Director, Clinical Practice Guidelines, Research Translation |
+61 (03) 8866 0407 | Mon - Thurs | nhmrc.gov.au/guidelinesforguidelines
https://nhmrc.gov.au/research‐policy/aboriginal‐and‐torres‐strait‐islander‐health
From:
Sent: Monday, 14 February 2022 1:07 PM
To: Goodrick, Stephanie <xxxxxxxxx.xxxxxxxx@xxxxx.xxx.xx>
Cc: Hoffman, Sharon <xxxxxx.xxxxxxx@xxxxx.xxx.xx>;
Mark Bellgrove <xxxx.xxxxxxxxx@xxxxxx.xxx>
Subject: Re: NHMRC Meetings 2022 [SEC=OFFICIAL]
2
Dear Stephanie,
I hope you are having a great start to the year!
We are preparing for public consultation early March for 1 month. We will
notify you two weeks before, if not sooner, of the publication start date; and
send you the documents associated with the public consultation process a
week before. Do let me know if we should send these to an email other than
xxxxxxxxxxxxxxxxxx@xxxxx.xxx.xx (Sally Wright).
We have followed the NHMRC procedures and requirements very carefully
through the entire development process. We would like to clarify how many
independent expert reviewers' contact details would you like us to send you?
And would you like these details when we submit the guideline to you or
sooner?
Finally, is it possible to have a deadline date for when we should submit to
you in order to be considered for the July 2022 council meeting?
Thank you and best wishes,
Monash University Teaching Associate, Faculty of Medicine,
Nursing & Health Sciences
E:
I acknowledge the Traditional Owners and Custodians of the
lands on which I live and work and pay my respect to Elders
both past and present.
On 7/02/2022 9:36 am, Duggan, Geraint wrote:
Hi Mark
I write earlier in the year advising of the Council dates for the rest of
the triennium, but it sounds like it didn’t get to you.
The dates are:
26/7 July 2022 23/24 November 2022
29/30 March 2023
26/27 July 2023
29/30 November 2023
27/28 March 2024
26/27 June 2024
(I have included later dates in case you plan to update the
guideline).
The procedures for public consultation and submission and
submission (stages 3 and 4) are laid out in the NHMRC procedures
and requirements which I urge you and your team to review before
you plan public consultation. Please contact Sharon Hoffman
(copied) who can set up a time with the NHMRC team to run
through what happens next. The timelines for the next few months
will be very tight.
3
You should also put together a list of Australian and international
experts unconnected with the guideline development process that
NHMRC can approach for expert review.
Regards
Geraint
From: Mark Bellgrove <xxxx.xxxxxxxxx@xxxxxx.xxx>
Sent: Saturday, 5 February 2022 2:56 PM
To: Duggan, Geraint <xxxxxxx.xxxxxx@xxxxx.xxx.xx>
Cc: Hoffman, Sharon <xxxxxx.xxxxxxx@xxxxx.xxx.xx>; Goodrick,
Stephanie <xxxxxxxxx.xxxxxxxx@xxxxx.xxx.xx>;
Subject: Re: NHMRC Meetings 2022 [SEC=OFFICIAL]
Hello Geraint, we are trying to work out timeline. Do you have
a meeting date yet for June, even early, mid or late would help.
Best
Mark
On 26 Oct 2021, at 12:21 pm, Duggan, Geraint
<xxxxxxx.xxxxxx@xxxxx.xxx.xx> wrote:
Hi Mark
Unfortunately not yet.
Our new Council has just been appointed and we
are expecting dates to be announced any day now.
We have your guideline booked in for a meeting
expected around March 2022, however because of
COVID related delays the agenda is very congested.
If there is the possibility that you would submit for a
mid‐year meeting instead (expected in June) it
would be helpful to know this asap.
As soon as we get confirmation of Council dates and
your preferred date for submission Sharon (copied)
will contact you to go through the next stepsin
detail.
Thanks
Geraint
Geraint Duggan
Director, Clinical Guidelines
4
Research Translation Branch
National Health and Medical Research Council
xxxxxxx.xxxxxx@xxxxx.xxx.xx
+61 3 8866 0403 / 0414 045 550
nhmrc.gov.au
From: Mark Bellgrove
<xxxx.xxxxxxxxx@xxxxxx.xxx>
Sent: Tuesday, 26 October 2021 9:55 AM
To: Duggan, Geraint
<xxxxxxx.xxxxxx@xxxxx.xxx.xx>;
Subject: NHMRC Meetings 2022
Dear Geraint,
Would you happen to know when the schedule
for the NHMRC guideline review meetings will
be for 2022, just to assist our planning?
best
Mark
--
PROFESSOR MARK A. BELLGROVE
Director of Research, Turner Institute for Brain and Mental
Health
National Health and Medical Research Council (NHMRC)
Senior Research Fellow
President, Australian ADHD Professionals Association
(AADPA) Ltd
Turner Institute for Brain and Mental Health
School of Psychological Sciences
Monash University
Room 540, 18 Innovation Walk
Clayton Campus, Clayton VIC 3800
Australia
T:
E: xxxx.xxxxxxxxx@xxxxxx.xxx
ORCID: orcid.org/0000-0003-0186-8349
http://www.monash.edu.au/research/profiles/profile.html?si
d=1985044&pid=6456
5
http://www.monash.edu/turner-institute/
I acknowledge the Traditional Owners and Custodians of the
lands on which I live and work and pay my respect to Elders
both past and present
This email (including any attached
files) is intended only for the
addressee, it may contain confidential
information. If you are not the
addressee, you are notified that any
transmission, distribution, printing
or duplication of this email is
strictly prohibited. If you have
received this email in error please
promptly inform the sender and delete
all copies of this e-mail and all
attachments.
Unless explicitly attributed, the
opinions expressed do not necessarily
represent the official position of the
National Health and Medical Research
Council.
Please consider the environment before
printing this email, thank you.
This email (including any attached files) is
intended only for the addressee, it may contain
confidential information. If you are not the
addressee, you are notified that any transmission,
distribution, printing or duplication of this
email is strictly prohibited. If you have received
this email in error please promptly inform the
sender and delete all copies of this e-mail and
all attachments.
Unless explicitly attributed, the opinions
expressed do not necessarily represent the
official position of the National Health and
Medical Research Council.
Please consider the environment before printing
this email, thank you.
This email (including any attached files) is intended only for
the addressee, it may contain confidential information. If you
are not the addressee, you are notified that any transmission,
distribution, printing or duplication of this email is
strictly prohibited. If you have received this email in error
please promptly inform the sender and delete all copies of
this e-mail and all attachments.
Unless explicitly attributed, the opinions expressed do not
necessarily represent the official position of the National
Health and Medical Research Council.
Please consider the environment before printing this email,
thank you.
This email (including any attached files) is intended only for the
addressee, it may contain confidential information. If you are not the
addressee, you are notified that any transmission, distribution, printing
or duplication of this email is strictly prohibited. If you have received
this email in error please promptly inform the sender and delete all
copies of this e-mail and all attachments.
Unless explicitly attributed, the opinions expressed do not necessarily
represent the official position of the National Health and Medical
Research Council.
6
Please consider the environment before printing this email, thank you.
7
